High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma

Background Prognosis of patients with hepatocellular carcinoma (HCC) remains poor because HCC is frequently diagnosed late. Therefore, regular surveillance has been recommended to detect HCC at the early stage when curative treatments can be applied. HCC biomarkers, including Lens culinaris agglutin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of gastroenterology 2014-03, Vol.49 (3), p.555-563
Hauptverfasser: Kumada, Takashi, Toyoda, Hidenori, Tada, Toshifumi, Kiriyama, Seiki, Tanikawa, Makoto, Hisanaga, Yasuhiro, Kanamori, Akira, Tanaka, Junko, Kagebayashi, Chiaki, Satomura, Shinji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 563
container_issue 3
container_start_page 555
container_title Journal of gastroenterology
container_volume 49
creator Kumada, Takashi
Toyoda, Hidenori
Tada, Toshifumi
Kiriyama, Seiki
Tanikawa, Makoto
Hisanaga, Yasuhiro
Kanamori, Akira
Tanaka, Junko
Kagebayashi, Chiaki
Satomura, Shinji
description Background Prognosis of patients with hepatocellular carcinoma (HCC) remains poor because HCC is frequently diagnosed late. Therefore, regular surveillance has been recommended to detect HCC at the early stage when curative treatments can be applied. HCC biomarkers, including Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3), are widely used for surveillance in Japan. A newly developed immunoassay system measures AFP-L3 % with high sensitivity. This retrospective study aimed to evaluate clinical utility of high-sensitivity AFP-L3 (hs-AFP-L3) as a predictor of early stage HCC in surveillance at a single site. Methods Of consecutive 2830 patients in the surveillance between 2000 and 2009, 104 HCC-developed and 104 non-HCC patients were selected by eligibility criteria and propensity score matching. Samples were obtained from the HCC patients who had blood drawn annually for 3 years prior to HCC diagnosis. Results In the present study, hs-AFP-L3 was elevated 1 year prior to diagnosis in 34.3 % of patients. The survival rate of patients with the hs-AFP-L3 ≥ 7 % at 1 year prior to diagnosis was significantly lower than that of patients with hs-AFP-L3 
doi_str_mv 10.1007/s00535-013-0883-1
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3953543</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A714584231</galeid><sourcerecordid>A714584231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c627t-f86c21f90bbb16ec5ecc8ccbe63c9ee21d5824fd8abf1404f25c997685b793ee3</originalsourceid><addsrcrecordid>eNp1kk9v1DAQxSMEokvhA3BBlrhwSfHfOLkgVRVtkVbiAmfLccZZV1k72E6lvfWj47CltAjkg62Z33vWjF5VvSX4jGAsPyaMBRM1JqzGbctq8qzaEF4qoqP0ebXBHec1IZKfVK9SusEFxKJ9WZ1QjoUkDdtUd9du3NUJfHLZ3bp8QNvyRmaZnNfRJaTHcVqy887XEbQpECA9zTtdW8hhjiGD80inpA9ojjA4kxMCHacDGiBDEQSPgkU7mHUOBqZpmXRERkfjfNjr19ULq6cEb-7v0-r75edvF9f19uvVl4vzbW0aKnNt28ZQYjvc9z1pwAgwpjWmh4aZDoCSQbSU26HVvSUcc0uF6TrZtKKXHQNgp9Wno--89HsYDPgc9aTm6PY6HlTQTj3teLdTY7hVrCs75qwYfLg3iOHHAimrvUvrPNpDWJIiAkvZESF5Qd__hd6EJfoy3i-KUMYx_kONegLlvA3lX7OaqnNJuGg5ZaRQZ_-gyhlg70zwYF2pPxGQo8DEkFIE-zAjwWqNjTrGRpU0qDU2atW8e7ycB8XvnBSAHoFUWn6E-Gii_7r-BCTA0Js</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1507123400</pqid></control><display><type>article</type><title>High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Kumada, Takashi ; Toyoda, Hidenori ; Tada, Toshifumi ; Kiriyama, Seiki ; Tanikawa, Makoto ; Hisanaga, Yasuhiro ; Kanamori, Akira ; Tanaka, Junko ; Kagebayashi, Chiaki ; Satomura, Shinji</creator><creatorcontrib>Kumada, Takashi ; Toyoda, Hidenori ; Tada, Toshifumi ; Kiriyama, Seiki ; Tanikawa, Makoto ; Hisanaga, Yasuhiro ; Kanamori, Akira ; Tanaka, Junko ; Kagebayashi, Chiaki ; Satomura, Shinji</creatorcontrib><description>Background Prognosis of patients with hepatocellular carcinoma (HCC) remains poor because HCC is frequently diagnosed late. Therefore, regular surveillance has been recommended to detect HCC at the early stage when curative treatments can be applied. HCC biomarkers, including Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3), are widely used for surveillance in Japan. A newly developed immunoassay system measures AFP-L3 % with high sensitivity. This retrospective study aimed to evaluate clinical utility of high-sensitivity AFP-L3 (hs-AFP-L3) as a predictor of early stage HCC in surveillance at a single site. Methods Of consecutive 2830 patients in the surveillance between 2000 and 2009, 104 HCC-developed and 104 non-HCC patients were selected by eligibility criteria and propensity score matching. Samples were obtained from the HCC patients who had blood drawn annually for 3 years prior to HCC diagnosis. Results In the present study, hs-AFP-L3 was elevated 1 year prior to diagnosis in 34.3 % of patients. The survival rate of patients with the hs-AFP-L3 ≥ 7 % at 1 year prior to diagnosis was significantly lower than that of patients with hs-AFP-L3 &lt; 7 %. Conclusions Elevation of hs-AFP-L3 was early predictive of development of HCC even at low AFP levels and in absence of ultrasound findings of suspicious HCC. The hs-AFP-L3 should be added to surveillance programs with US because elevated hs-AFP-L3 may be a trigger to perform enhanced imaging modalities for confirmation of HCC.</description><identifier>ISSN: 0944-1174</identifier><identifier>EISSN: 1435-5922</identifier><identifier>DOI: 10.1007/s00535-013-0883-1</identifier><identifier>PMID: 24057163</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Abdominal Surgery ; Adult ; Aged ; Aged, 80 and over ; Alpha fetoproteins ; alpha-Fetoproteins - analysis ; Biliary Tract ; Biomarkers, Tumor - blood ; Cancer ; Carcinoma, Hepatocellular - diagnosis ; Carcinoma, Hepatocellular - pathology ; Colorectal Surgery ; Diagnosis ; Early Detection of Cancer ; Female ; Gastroenterology ; Glycoproteins ; Hepatology ; Hepatoma ; Humans ; Japan ; Liver Neoplasms - diagnosis ; Liver Neoplasms - pathology ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Original Article—Liver ; Original —Liver, Pancreas, and Biliary Tract ; Pancreas ; Plant Lectins ; Prognosis ; Propensity Score ; Retrospective Studies ; Sensitivity and Specificity ; Surgical Oncology ; Time Factors ; Young Adult</subject><ispartof>Journal of gastroenterology, 2014-03, Vol.49 (3), p.555-563</ispartof><rights>The Author(s) 2013</rights><rights>COPYRIGHT 2014 Springer</rights><rights>Springer Japan 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c627t-f86c21f90bbb16ec5ecc8ccbe63c9ee21d5824fd8abf1404f25c997685b793ee3</citedby><cites>FETCH-LOGICAL-c627t-f86c21f90bbb16ec5ecc8ccbe63c9ee21d5824fd8abf1404f25c997685b793ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00535-013-0883-1$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00535-013-0883-1$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24057163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumada, Takashi</creatorcontrib><creatorcontrib>Toyoda, Hidenori</creatorcontrib><creatorcontrib>Tada, Toshifumi</creatorcontrib><creatorcontrib>Kiriyama, Seiki</creatorcontrib><creatorcontrib>Tanikawa, Makoto</creatorcontrib><creatorcontrib>Hisanaga, Yasuhiro</creatorcontrib><creatorcontrib>Kanamori, Akira</creatorcontrib><creatorcontrib>Tanaka, Junko</creatorcontrib><creatorcontrib>Kagebayashi, Chiaki</creatorcontrib><creatorcontrib>Satomura, Shinji</creatorcontrib><title>High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma</title><title>Journal of gastroenterology</title><addtitle>J Gastroenterol</addtitle><addtitle>J Gastroenterol</addtitle><description>Background Prognosis of patients with hepatocellular carcinoma (HCC) remains poor because HCC is frequently diagnosed late. Therefore, regular surveillance has been recommended to detect HCC at the early stage when curative treatments can be applied. HCC biomarkers, including Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3), are widely used for surveillance in Japan. A newly developed immunoassay system measures AFP-L3 % with high sensitivity. This retrospective study aimed to evaluate clinical utility of high-sensitivity AFP-L3 (hs-AFP-L3) as a predictor of early stage HCC in surveillance at a single site. Methods Of consecutive 2830 patients in the surveillance between 2000 and 2009, 104 HCC-developed and 104 non-HCC patients were selected by eligibility criteria and propensity score matching. Samples were obtained from the HCC patients who had blood drawn annually for 3 years prior to HCC diagnosis. Results In the present study, hs-AFP-L3 was elevated 1 year prior to diagnosis in 34.3 % of patients. The survival rate of patients with the hs-AFP-L3 ≥ 7 % at 1 year prior to diagnosis was significantly lower than that of patients with hs-AFP-L3 &lt; 7 %. Conclusions Elevation of hs-AFP-L3 was early predictive of development of HCC even at low AFP levels and in absence of ultrasound findings of suspicious HCC. The hs-AFP-L3 should be added to surveillance programs with US because elevated hs-AFP-L3 may be a trigger to perform enhanced imaging modalities for confirmation of HCC.</description><subject>Abdominal Surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alpha fetoproteins</subject><subject>alpha-Fetoproteins - analysis</subject><subject>Biliary Tract</subject><subject>Biomarkers, Tumor - blood</subject><subject>Cancer</subject><subject>Carcinoma, Hepatocellular - diagnosis</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Colorectal Surgery</subject><subject>Diagnosis</subject><subject>Early Detection of Cancer</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Glycoproteins</subject><subject>Hepatology</subject><subject>Hepatoma</subject><subject>Humans</subject><subject>Japan</subject><subject>Liver Neoplasms - diagnosis</subject><subject>Liver Neoplasms - pathology</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Original Article—Liver</subject><subject>Original —Liver, Pancreas, and Biliary Tract</subject><subject>Pancreas</subject><subject>Plant Lectins</subject><subject>Prognosis</subject><subject>Propensity Score</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><subject>Surgical Oncology</subject><subject>Time Factors</subject><subject>Young Adult</subject><issn>0944-1174</issn><issn>1435-5922</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kk9v1DAQxSMEokvhA3BBlrhwSfHfOLkgVRVtkVbiAmfLccZZV1k72E6lvfWj47CltAjkg62Z33vWjF5VvSX4jGAsPyaMBRM1JqzGbctq8qzaEF4qoqP0ebXBHec1IZKfVK9SusEFxKJ9WZ1QjoUkDdtUd9du3NUJfHLZ3bp8QNvyRmaZnNfRJaTHcVqy887XEbQpECA9zTtdW8hhjiGD80inpA9ojjA4kxMCHacDGiBDEQSPgkU7mHUOBqZpmXRERkfjfNjr19ULq6cEb-7v0-r75edvF9f19uvVl4vzbW0aKnNt28ZQYjvc9z1pwAgwpjWmh4aZDoCSQbSU26HVvSUcc0uF6TrZtKKXHQNgp9Wno--89HsYDPgc9aTm6PY6HlTQTj3teLdTY7hVrCs75qwYfLg3iOHHAimrvUvrPNpDWJIiAkvZESF5Qd__hd6EJfoy3i-KUMYx_kONegLlvA3lX7OaqnNJuGg5ZaRQZ_-gyhlg70zwYF2pPxGQo8DEkFIE-zAjwWqNjTrGRpU0qDU2atW8e7ycB8XvnBSAHoFUWn6E-Gii_7r-BCTA0Js</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Kumada, Takashi</creator><creator>Toyoda, Hidenori</creator><creator>Tada, Toshifumi</creator><creator>Kiriyama, Seiki</creator><creator>Tanikawa, Makoto</creator><creator>Hisanaga, Yasuhiro</creator><creator>Kanamori, Akira</creator><creator>Tanaka, Junko</creator><creator>Kagebayashi, Chiaki</creator><creator>Satomura, Shinji</creator><general>Springer Japan</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140301</creationdate><title>High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma</title><author>Kumada, Takashi ; Toyoda, Hidenori ; Tada, Toshifumi ; Kiriyama, Seiki ; Tanikawa, Makoto ; Hisanaga, Yasuhiro ; Kanamori, Akira ; Tanaka, Junko ; Kagebayashi, Chiaki ; Satomura, Shinji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c627t-f86c21f90bbb16ec5ecc8ccbe63c9ee21d5824fd8abf1404f25c997685b793ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Abdominal Surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alpha fetoproteins</topic><topic>alpha-Fetoproteins - analysis</topic><topic>Biliary Tract</topic><topic>Biomarkers, Tumor - blood</topic><topic>Cancer</topic><topic>Carcinoma, Hepatocellular - diagnosis</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Colorectal Surgery</topic><topic>Diagnosis</topic><topic>Early Detection of Cancer</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Glycoproteins</topic><topic>Hepatology</topic><topic>Hepatoma</topic><topic>Humans</topic><topic>Japan</topic><topic>Liver Neoplasms - diagnosis</topic><topic>Liver Neoplasms - pathology</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Original Article—Liver</topic><topic>Original —Liver, Pancreas, and Biliary Tract</topic><topic>Pancreas</topic><topic>Plant Lectins</topic><topic>Prognosis</topic><topic>Propensity Score</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><topic>Surgical Oncology</topic><topic>Time Factors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumada, Takashi</creatorcontrib><creatorcontrib>Toyoda, Hidenori</creatorcontrib><creatorcontrib>Tada, Toshifumi</creatorcontrib><creatorcontrib>Kiriyama, Seiki</creatorcontrib><creatorcontrib>Tanikawa, Makoto</creatorcontrib><creatorcontrib>Hisanaga, Yasuhiro</creatorcontrib><creatorcontrib>Kanamori, Akira</creatorcontrib><creatorcontrib>Tanaka, Junko</creatorcontrib><creatorcontrib>Kagebayashi, Chiaki</creatorcontrib><creatorcontrib>Satomura, Shinji</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumada, Takashi</au><au>Toyoda, Hidenori</au><au>Tada, Toshifumi</au><au>Kiriyama, Seiki</au><au>Tanikawa, Makoto</au><au>Hisanaga, Yasuhiro</au><au>Kanamori, Akira</au><au>Tanaka, Junko</au><au>Kagebayashi, Chiaki</au><au>Satomura, Shinji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma</atitle><jtitle>Journal of gastroenterology</jtitle><stitle>J Gastroenterol</stitle><addtitle>J Gastroenterol</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>49</volume><issue>3</issue><spage>555</spage><epage>563</epage><pages>555-563</pages><issn>0944-1174</issn><eissn>1435-5922</eissn><abstract>Background Prognosis of patients with hepatocellular carcinoma (HCC) remains poor because HCC is frequently diagnosed late. Therefore, regular surveillance has been recommended to detect HCC at the early stage when curative treatments can be applied. HCC biomarkers, including Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3), are widely used for surveillance in Japan. A newly developed immunoassay system measures AFP-L3 % with high sensitivity. This retrospective study aimed to evaluate clinical utility of high-sensitivity AFP-L3 (hs-AFP-L3) as a predictor of early stage HCC in surveillance at a single site. Methods Of consecutive 2830 patients in the surveillance between 2000 and 2009, 104 HCC-developed and 104 non-HCC patients were selected by eligibility criteria and propensity score matching. Samples were obtained from the HCC patients who had blood drawn annually for 3 years prior to HCC diagnosis. Results In the present study, hs-AFP-L3 was elevated 1 year prior to diagnosis in 34.3 % of patients. The survival rate of patients with the hs-AFP-L3 ≥ 7 % at 1 year prior to diagnosis was significantly lower than that of patients with hs-AFP-L3 &lt; 7 %. Conclusions Elevation of hs-AFP-L3 was early predictive of development of HCC even at low AFP levels and in absence of ultrasound findings of suspicious HCC. The hs-AFP-L3 should be added to surveillance programs with US because elevated hs-AFP-L3 may be a trigger to perform enhanced imaging modalities for confirmation of HCC.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>24057163</pmid><doi>10.1007/s00535-013-0883-1</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0944-1174
ispartof Journal of gastroenterology, 2014-03, Vol.49 (3), p.555-563
issn 0944-1174
1435-5922
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3953543
source MEDLINE; SpringerLink Journals
subjects Abdominal Surgery
Adult
Aged
Aged, 80 and over
Alpha fetoproteins
alpha-Fetoproteins - analysis
Biliary Tract
Biomarkers, Tumor - blood
Cancer
Carcinoma, Hepatocellular - diagnosis
Carcinoma, Hepatocellular - pathology
Colorectal Surgery
Diagnosis
Early Detection of Cancer
Female
Gastroenterology
Glycoproteins
Hepatology
Hepatoma
Humans
Japan
Liver Neoplasms - diagnosis
Liver Neoplasms - pathology
Male
Medicine
Medicine & Public Health
Middle Aged
Original Article—Liver
Original —Liver, Pancreas, and Biliary Tract
Pancreas
Plant Lectins
Prognosis
Propensity Score
Retrospective Studies
Sensitivity and Specificity
Surgical Oncology
Time Factors
Young Adult
title High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T03%3A19%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High-sensitivity%20Lens%20culinaris%20agglutinin-reactive%20alpha-fetoprotein%20assay%20predicts%20early%20detection%20of%20hepatocellular%20carcinoma&rft.jtitle=Journal%20of%20gastroenterology&rft.au=Kumada,%20Takashi&rft.date=2014-03-01&rft.volume=49&rft.issue=3&rft.spage=555&rft.epage=563&rft.pages=555-563&rft.issn=0944-1174&rft.eissn=1435-5922&rft_id=info:doi/10.1007/s00535-013-0883-1&rft_dat=%3Cgale_pubme%3EA714584231%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1507123400&rft_id=info:pmid/24057163&rft_galeid=A714584231&rfr_iscdi=true